Your browser doesn't support javascript.
Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing.
Kaul, Daniel R; Valesano, Andrew L; Petrie, Joshua G; Sagana, Rommel; Lyu, Dennis; Lin, Jules; Stoneman, Emily; Smith, Lane M; Lephart, Paul; Lauring, Adam S.
  • Kaul DR; Division of Infectious Disease, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Valesano AL; Division of Infectious Disease, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Petrie JG; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.
  • Sagana R; Division of Pulmonary Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Lyu D; Division of Pulmonary Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Lin J; Division of Thoracic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan.
  • Stoneman E; Division of Infectious Disease, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Smith LM; Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Lephart P; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Lauring AS; Division of Infectious Disease, Department of Internal Medicine and Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan.
Am J Transplant ; 21(8): 2885-2889, 2021 08.
Article in English | MEDLINE | ID: covidwho-1075766
ABSTRACT
We describe a case of proven transmission of SARS-CoV-2 from lung donor to recipient. The donor had no clinical history or findings suggestive of infection with SARS-CoV-2 and tested negative by reverse transcriptase polymerase chain reaction (RT-PCR) on a nasopharyngeal (NP) swab obtained within 48 h of procurement. Lower respiratory tract testing was not performed. The recipient developed fever, hypotension, and pulmonary infiltrates on posttransplant day (PTD) 3, and RT-PCR testing for SARS-CoV-2 on an NP swab specimen was non-reactive, but positive on bronchoalveolar lavage (BAL) fluid. One thoracic surgeon present during the transplantation procedure developed COVID-19. Sequence analysis of isolates from donor BAL fluid (obtained at procurement), the recipient, and the infected thoracic surgeon proved donor origin of recipient and health-care worker (HCW) infection. No other organs were procured from this donor. Transplant centers and organ procurement organizations should perform SARS-CoV-2 testing of lower respiratory tract specimens from potential lung donors, and consider enhanced personal protective equipment for HCWs involved in lung procurement and transplantation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Transplantation / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Transplantation / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2021 Document Type: Article